On the public citation graph

mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway

0 signed · 124 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/bies.10153openalex-snapshot
Non‐stop decay—a new mRNA surveillance pathway
inferredcites →https://doi.org/10.1002/wrna.17openalex-snapshot
No‐go decay: a quality control mechanism for RNA in translation
inferredcites →https://doi.org/10.1002/wrna.25openalex-snapshot
RNA decay modulates gene expression and controls its fidelity
inferredcites →https://doi.org/10.1002/wrna.40openalex-snapshot
Mechanisms of deadenylation‐dependent decay
inferredcites →https://doi.org/10.1007/978-1-4939-8651-4_4openalex-snapshot
Nusinersen in the Treatment of Spinal Muscular Atrophy
inferredcites →https://doi.org/10.1007/s40262-014-0224-4openalex-snapshot
Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B
inferredcites →https://doi.org/10.1016/j.ceb.2005.04.005openalex-snapshot
Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species
inferredcites →https://doi.org/10.1016/j.cmet.2018.03.004openalex-snapshot
RNA-Targeted Therapeutics
inferredcites →https://doi.org/10.1016/j.molcel.2004.06.031openalex-snapshot
Regulation of mRNA Decay
inferredcites →https://doi.org/10.1016/j.molcel.2017.08.019openalex-snapshot
Ribosome Collision Is Critical for Quality Control during No-Go Decay
inferredcites →https://doi.org/10.1016/j.plantsci.2018.07.008openalex-snapshot
The No-go decay system degrades plant mRNAs that contain a long A-stretch in the coding region
inferredcites →https://doi.org/10.1016/j.sbi.2005.05.006openalex-snapshot
Post-transcriptional gene silencing by siRNAs and miRNAs
inferredcites →https://doi.org/10.1016/j.tet.2004.06.009openalex-snapshot
Synthesis and acid catalyzed hydrolysis of B2,5 type conformationally constrained glucopyranosides: incorporation into a cellobiose analogue
inferredcites →https://doi.org/10.1016/j.tig.2016.08.007openalex-snapshot
A Universal Code for mRNA Stability?
inferredcites →https://doi.org/10.1016/j.ymthe.2017.06.002openalex-snapshot
RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus
inferredcites →https://doi.org/10.1016/s0167-4781(99)00141-4openalex-snapshot
Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides
inferredcites →https://doi.org/10.1016/s1359-6446(01)02123-7openalex-snapshot
Antisense Drug Technology: Principles, Strategies, and Applications
inferredcites →https://doi.org/10.1021/jo902560fopenalex-snapshot
Synthesis and Biophysical Evaluation of 2′,4′-Constrained 2′ O -Methoxyethyl and 2′,4′-Constrained 2′ O -Ethyl Nucleic Acid Analogues
inferredcites →https://doi.org/10.1038/nature04530openalex-snapshot
Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation
inferredcites →https://doi.org/10.1038/nbt.3427openalex-snapshot
Antisense oligonucleotide–directed inhibition of nonsense-mediated mRNA decay
inferredcites →https://doi.org/10.1038/nbt.3589openalex-snapshot
Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames
inferredcites →https://doi.org/10.1038/nbt.3779openalex-snapshot
Cellular uptake and trafficking of antisense oligonucleotides
inferredcites →https://doi.org/10.1038/nchembio.939openalex-snapshot
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
inferredcites →https://doi.org/10.1038/ncomms13521openalex-snapshot
Structural insights into ribosomal rescue by Dom34 and Hbs1 at near-atomic resolution
inferredcites →https://doi.org/10.1038/nrm2104openalex-snapshot
The highways and byways of mRNA decay
inferredcites →https://doi.org/10.1038/nrm4063openalex-snapshot
Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes
inferredcites →https://doi.org/10.1038/nsmb.1922openalex-snapshot
Structure of the Dom34–Hbs1 complex and implications for no-go decay
inferredcites →https://doi.org/10.1038/nsmb.2057openalex-snapshot
Structure of the no-go mRNA decay complex Dom34–Hbs1 bound to a stalled 80S ribosome
inferredcites →https://doi.org/10.1038/srep29295openalex-snapshot
Mutations in the G-domain of Ski7 cause specific dysfunction in non-stop decay
inferredcites →https://doi.org/10.1042/bst0381615openalex-snapshot
Cutting the nonsense: the degradation of PTC-containing mRNAs
inferredcites →https://doi.org/10.1046/j.1432-1033.2003.03555.xopenalex-snapshot
Antisense technologies
inferredcites →https://doi.org/10.1073/pnas.0905780106openalex-snapshot
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
inferredcites →https://doi.org/10.1074/jbc.271.24.14533openalex-snapshot
Nuclease Resistance and Antisense Activity of Modified Oligonucleotides Targeted to Ha-
inferredcites →https://doi.org/10.1074/jbc.m112.448977openalex-snapshot
The Hbs1-Dom34 Protein Complex Functions in Non-stop mRNA Decay in Mammalian Cells
inferredcites →https://doi.org/10.1089/nat.2015.0576openalex-snapshot
Development of a Method for Profiling Protein Interactions with LNA-Modified Antisense Oligonucleotides Using Protein Microarrays
inferredcites →https://doi.org/10.1089/oli.1.2000.10.117openalex-snapshot
Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?
inferredcites →https://doi.org/10.1091/mbc.e09-01-0028openalex-snapshot
Analysis of Dom34 and Its Function in No-Go Decay
inferredcites →https://doi.org/10.1093/hmg/7.7.1083openalex-snapshot
Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides
inferredcites →https://doi.org/10.1093/nar/19.5.1113openalex-snapshot
Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism
inferredcites →https://doi.org/10.1093/nar/25.22.4429openalex-snapshot
The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexes
inferredcites →https://doi.org/10.1093/nar/29.6.1293openalex-snapshot
Fully modified 2' MOE oligonucleotides redirect polyadenylation
inferredcites →https://doi.org/10.1093/nar/gkq1121openalex-snapshot
Efficient and specific knockdown of small non-coding RNAs in mammalian cells and in mice
inferredcites →https://doi.org/10.1093/nar/gku1311openalex-snapshot
Small antisense oligonucleotides against G-quadruplexes: specific mRNA translational switches
inferredcites →https://doi.org/10.1093/nar/gku184openalex-snapshot
Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotides
inferredcites →https://doi.org/10.1093/nar/gku484openalex-snapshot
TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells
inferredcites →https://doi.org/10.1093/nar/gku579openalex-snapshot
Phosphorothioate oligonucleotides can displaceNEAT1RNA and form nuclear paraspeckle-like structures
inferredcites →https://doi.org/10.1093/nar/gkv143openalex-snapshot
Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages
inferredcites →https://doi.org/10.1093/nar/gkv298openalex-snapshot
2′-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF
inferredcites →https://doi.org/10.1093/nar/gkw065openalex-snapshot
RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery
inferredcites →https://doi.org/10.1093/nar/gkw144openalex-snapshot
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2′-modifications and enhances antisense activity
inferredcites →https://doi.org/10.1093/nar/gkw595openalex-snapshot
Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides
inferredcites →https://doi.org/10.1093/nar/gkx1174openalex-snapshot
Translation can affect the antisense activity of RNase H1-dependent oligonucleotides targeting mRNAs
inferredcites →https://doi.org/10.1093/nar/gkx632openalex-snapshot
Antisense oligonucleotides targeting translation inhibitory elements in 5′ UTRs can selectively increase protein levels
inferredcites →https://doi.org/10.1093/nar/gkx709openalex-snapshot
Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides
inferredcites →https://doi.org/10.1093/nar/gky145openalex-snapshot
Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides
inferredcites →https://doi.org/10.1093/nar/gky841openalex-snapshot
COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways
inferredcites →https://doi.org/10.1146/annurev-pharmtox-010716-104846openalex-snapshot
Pharmacology of Antisense Drugs
inferredcites →https://doi.org/10.1146/annurev.biochem.73.011303.074032openalex-snapshot
Eukaryotic mRNA Decapping
inferredcites →https://doi.org/10.1146/annurev.pharmtox.010909.105654openalex-snapshot
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
inferredcites →https://doi.org/10.1186/s13059-017-1386-9openalex-snapshot
Antisense suppression of the nonsense mediated decay factor Upf3b as a potential treatment for diseases caused by nonsense mutations
inferredcites →https://doi.org/10.1201/9781420002546openalex-snapshot
Antisense Drug Technology
inferredcites →https://doi.org/10.1261/rna.059055.116openalex-snapshot
Transcriptome-wide identification of NMD-targeted human mRNAs reveals extensive redundancy between SMG6- and SMG7-mediated degradation pathways
inferredcites →https://doi.org/10.1371/journal.pbio.0050073openalex-snapshot
Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon
inferredcites →https://doi.org/10.1371/journal.pgen.1007818openalex-snapshot
Interactions between the mRNA and Rps3/uS3 at the entry tunnel of the ribosomal small subunit are important for no-go decay
inferredcites →https://doi.org/10.1371/journal.pone.0161930openalex-snapshot
Development of a Quantitative BRET Affinity Assay for Nucleic Acid-Protein Interactions
inferredcites →https://doi.org/10.3389/fgene.2018.00431openalex-snapshot
Lost in Translation: Ribosome-Associated mRNA and Protein Quality Controls
inferredcites →https://doi.org/10.4161/cc.4.3.1520openalex-snapshot
siRNA Induced Transcriptional Gene Silencing in Mammalian Cells

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4765473openalex-extracted
Tmprss2-Specific Antisense Oligonucleotides Inhibit Emerging Viruses Entry
inferred← citeshttps://doi.org/10.1002/nadc.20214111119openalex-snapshot
Trendbericht Biochemie: Translations‐Qualitätskontrolle
inferred← citeshttps://doi.org/10.1002/wnan.1809openalex-snapshot
Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery
inferred← citeshttps://doi.org/10.1002/wrna.1594openalex-snapshot
The powerful world of antisense oligonucleotides: From bench to bedside
inferred← citeshttps://doi.org/10.1007/s12035-021-02564-xopenalex-snapshot
LISTERIN E3 Ubiquitin Ligase and Ribosome-Associated Quality Control (RQC) Mechanism
inferred← citeshttps://doi.org/10.1007/s40259-025-00761-xopenalex-snapshot
Antisense Oligonucleotide Therapeutics Targeting Age-Related Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-813955-4.00017-9openalex-snapshot
Antisense oligonucleotide drugs for neurological and neuromuscular disease
inferred← citeshttps://doi.org/10.1016/b978-0-443-19041-4.00039-xopenalex-snapshot
Antisense oligonucleotide drugs for neurological and neuromuscular diseases
inferred← citeshttps://doi.org/10.1016/b978-0-443-27416-9.00007-1openalex-snapshot
RNA-based therapeutics—Mechanisms and challenges
inferred← citeshttps://doi.org/10.1016/j.addr.2021.114041openalex-snapshot
Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
inferred← citeshttps://doi.org/10.1016/j.bbcan.2024.189243openalex-snapshot
TERT promoter mutations in gliomas: Molecular roles in tumorigenesis, metastasis, diagnosis, prognosis, therapeutic targeting, and drug resistance
inferred← citeshttps://doi.org/10.1016/j.bcp.2020.114196openalex-snapshot
Antisense drug discovery and development technology considered in a pharmacological context
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2022.108047openalex-snapshot
CRISPR-Cas13 technology portfolio and alliance with other genetic tools
inferred← citeshttps://doi.org/10.1016/j.gde.2025.102369openalex-snapshot
Transcriptional adaptation: where mRNA decay meets genetic compensation
inferred← citeshttps://doi.org/10.1016/j.jbc.2021.100416openalex-snapshot
Antisense technology: A review
inferred← citeshttps://doi.org/10.1016/j.lfs.2026.124534openalex-snapshot
Inflammation-mediated diabetes-liver disease cross-organ crosstalk: From molecular mechanisms to precision therapeutic strategies
inferred← citeshttps://doi.org/10.1016/j.molcel.2024.06.026openalex-snapshot
The guide-RNA sequence dictates the slicing kinetics and conformational dynamics of the Argonaute silencing complex
inferred← citeshttps://doi.org/10.1016/j.omtn.2023.04.010openalex-snapshot
Block or degrade? Balancing on- and off-target effects of antisense strategies against transcripts with expanded triplet repeats in DM1
inferred← citeshttps://doi.org/10.1016/j.omtn.2025.102694openalex-snapshot
Antisense oligonucleotide-mediated upregulation of Jag1 ameliorates liver disease phenotypes in a mouse model of Alagille syndrome
inferred← citeshttps://doi.org/10.1016/j.virol.2024.110218openalex-snapshot
TMPRSS2-specific antisense oligonucleotides inhibit host cell entry of emerging viruses
inferred← citeshttps://doi.org/10.1021/acs.chemrev.4c00472openalex-snapshot
Technologies for Targeted RNA Degradation and Induced RNA Decay
inferred← citeshttps://doi.org/10.1021/acssynbio.5c00583openalex-snapshot
Exploration of Retron Elements for the Genetic Engineering of Acidithiobacillus ferrooxidans
inferred← citeshttps://doi.org/10.1021/jacs.3c06706openalex-snapshot
In-Cell Stability Prediction of RNA/DNA Hybrid Duplexes for Designing Oligonucleotides Aimed at Therapeutics
inferred← citeshttps://doi.org/10.1038/s41401-024-01261-4openalex-snapshot
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41420-025-02324-zopenalex-snapshot
Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health
inferred← citeshttps://doi.org/10.1038/s41467-023-38273-3openalex-snapshot
Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching
inferred← citeshttps://doi.org/10.1038/s41573-021-00162-zopenalex-snapshot
Antisense technology: an overview and prospectus
inferred← citeshttps://doi.org/10.1039/d4ra01925copenalex-snapshot
Inhibition of survivin by 2′- O -methyl phosphorothioate-modified steric-blocking antisense oligonucleotides
inferred← citeshttps://doi.org/10.1089/nat.2020.0847openalex-snapshot
Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy
inferred← citeshttps://doi.org/10.1089/nat.2020.0864openalex-snapshot
Gapmer Antisense Oligonucleotides Targeting 5S Ribosomal RNA Can Reduce Mature 5S Ribosomal RNA by Two Mechanisms
inferred← citeshttps://doi.org/10.1089/nat.2020.0923openalex-snapshot
Solid-Phase Separation of Toxic Phosphorothioate Antisense Oligonucleotide-Protein Nucleolar Aggregates Is Cytoprotective
inferred← citeshttps://doi.org/10.1089/nat.2021.0067openalex-snapshot
Modulation of RNA Splicing by Oligonucleotides: Mechanisms of Action and Therapeutic Implications
inferred← citeshttps://doi.org/10.1093/jjco/hyag017openalex-snapshot
Advances in antisense oligonucleotide treatment for cancer
inferred← citeshttps://doi.org/10.1093/nar/gkaa715openalex-snapshot
Some ASOs that bind in the coding region of mRNAs and induce RNase H1 cleavage can cause increases in the pre-mRNAs that may blunt total activity
inferred← citeshttps://doi.org/10.1093/nar/gkab599openalex-snapshot
Golgi-58K can re-localize to late endosomes upon cellular uptake of PS-ASOs and facilitates endosomal release of ASOs
inferred← citeshttps://doi.org/10.1093/nar/gkz1171openalex-snapshot
Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomes
inferred← citeshttps://doi.org/10.1097/ms9.0000000000001118openalex-snapshot
The promise of RNA-based therapeutics in revolutionizing heart failure management – a narrative review of current evidence
inferred← citeshttps://doi.org/10.1186/s10020-025-01358-4openalex-snapshot
Genomic medicine in hepatology: mechanisms and liver treatment strategies
inferred← citeshttps://doi.org/10.1186/s12864-026-12733-8openalex-snapshot
Differential expression of mitochondria-associated genes in clinical samples of Plasmodium falciparum showing severe manifestations
inferred← citeshttps://doi.org/10.1186/s12943-021-01338-2openalex-snapshot
RNA-based therapies: A cog in the wheel of lung cancer defense
inferred← citeshttps://doi.org/10.1186/s12951-026-04529-5openalex-snapshot
Bibliometric analysis of nanomaterials in the diagnosis and treatment of neurological and psychiatric disorders (1997–2025): trends and future directions
inferred← citeshttps://doi.org/10.1186/s12964-023-01385-wopenalex-snapshot
The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing
inferred← citeshttps://doi.org/10.1186/s13045-019-0805-7openalex-snapshot
The interplay between m6A RNA methylation and noncoding RNA in cancer
inferred← citeshttps://doi.org/10.15252/embj.2023114760openalex-snapshot
RNA‐based medicine: from molecular mechanisms to therapy
inferred← citeshttps://doi.org/10.3389/fchem.2020.00276openalex-snapshot
Transcription and Translation Inhibitors in Cancer Treatment
inferred← citeshttps://doi.org/10.3390/genes14071378openalex-snapshot
Therapeutic Targeting of RNA Splicing in Cancer
inferred← citeshttps://doi.org/10.3390/genes16121468openalex-snapshot
Artificial Intelligence-Driven Design of Antisense Oligonucleotides for Precision Medicine in Neuromuscular Disorders
inferred← citeshttps://doi.org/10.3390/ijms25169065openalex-snapshot
Oligonucleotide Therapies for Facioscapulohumeral Muscular Dystrophy: Current Preclinical Landscape
inferred← citeshttps://doi.org/10.3390/ijms262311536openalex-snapshot
The Fluidic Connectome in Brain Disease: Integrating Aquaporin-4 Polarity with Multisystem Pathways in Neurodegeneration
inferred← citeshttps://doi.org/10.3390/ijms27125612openalex-snapshot
The Versatile Applications of Antisense Oligonucleotides in Modern Medicine
inferred← citeshttps://doi.org/10.3390/molecules27020536openalex-snapshot
Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development
inferred← citeshttps://doi.org/10.3390/molecules29112658openalex-snapshot
Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA
inferred← citeshttps://doi.org/10.3390/molecules29245997openalex-snapshot
Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids
inferred← citeshttps://doi.org/10.3390/molecules31132283openalex-snapshot
Survivin-Targeting Antisense Oligonucleotides in Cancer Therapy
inferred← citeshttps://doi.org/10.4062/biomolther.2023.001openalex-snapshot
Drug Discovery Perspectives of Antisense Oligonucleotides
inferred← citeshttps://doi.org/10.70675/b6a2cadfz77d7z48b6zb573zaab26d81396eopenalex-snapshot
Mecanisme de regulation de l’activite du microARN miR-16 dans le melanome uveal
inferred← citeshttps://doi.org/10.70675/e85660d0z8d85z4942za160ze9c2cefba9d6openalex-snapshot
Analyse exploratoire des thérapies antisens innovantes dans le traitement des syndromes lymphoprolifératifs et autres maladies impliquant la lignée lymphoïde B
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.